Search Results - "Parker, Brittany"
-
1
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
Published in Nature communications (09-02-2022)“…A major rate-limiting step in developing more effective immunotherapies for GBM is our inadequate understanding of the cellular complexity and the molecular…”
Get full text
Journal Article -
2
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas
Published in Neuro-oncology (Charlottesville, Va.) (19-02-2018)“…MicroRNAs (miRs) are promising new therapeutics for glioblastoma. However, which miRs are most effective against glioblastomas and how these miRs should be…”
Get full text
Journal Article -
3
Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours
Published in The Journal of pathology (01-01-2014)“…The emergence of fibroblast growth factor receptor (FGFR) family fusions across diverse cancers has brought attention to FGFR‐derived cancer therapies. The…”
Get full text
Journal Article -
4
MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer
Published in The Journal of pathology (01-07-2014)“…Ovarian carcinoma is the most lethal gynaecological malignancy. Better understanding of the molecular pathogenesis of this disease and effective targeted…”
Get full text
Journal Article -
5
Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions
Published in Journal of hematology and oncology (05-03-2014)“…Epithelial-to-mesenchymal transition (EMT) and its reverse process, mesenchymal-to-epithelial transition (MET), play important roles in embryogenesis, stem…”
Get full text
Journal Article -
6
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma
Published in Journal of neurosurgery (01-03-2022)“…Delta-24-RGD is an oncolytic adenovirus that is capable of replicating in and killing human glioma cells. Although intratumoral delivery of Delta-24-RGD can be…”
Get full text
Journal Article -
7
Mesenchymal stromal cells for the delivery of oncolytic viruses in gliomas
Published in Cytotherapy (Oxford, England) (01-04-2017)“…Abstract Mesenchymal stromal cells (MSCs) are a type of adult stem cell that has been exploited for the treatment of a variety of diseases, including cancer…”
Get full text
Journal Article -
8
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
Published in The Journal of clinical investigation (01-02-2013)“…Fusion genes are chromosomal aberrations that are found in many cancers and can be used as prognostic markers and drug targets in clinical practice. Fusions…”
Get full text
Journal Article -
9
Parental Grief, Wrongful Incarceration, and the Continued Effects after Exoneration
Published in Journal of aggression, maltreatment & trauma (01-02-2023)“…The current article was motivated by a case study to diversify present literature on parental grief and wrongful conviction. The authors sought to accomplish…”
Get full text
Journal Article -
10
Ionizing radiation augments glioma tropism of mesenchymal stem cells
Published in Journal of neurosurgery (01-01-2018)“…OBJECTIVE Mesenchymal stem cells (MSCs) have been shown to localize to gliomas after intravascular delivery. Because these cells home to areas of tissue…”
Get full text
Journal Article -
11
HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion
Published in Molecular therapy (06-04-2022)“…The FGFR3-TACC3 (F3-T3) fusion gene was discovered as an oncogenic molecule in glioblastoma and bladder cancers, and has subsequently been found in many cancer…”
Get full text
Journal Article -
12
Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells
Published in Journal of neurosurgery (01-10-2020)“…Bone marrow-derived human mesenchymal stem cells (BM-hMSCs) have been used in clinical trials for the treatment of several neurological disorders. MSCs have…”
Get full text
Journal Article -
13
Tumor Vaccines for Malignant Gliomas
Published in Neurotherapeutics (01-04-2017)“…Despite continued research efforts, glioblastoma multiforme (GBM) remains the deadliest brain tumor. Immunotherapy offers a novel way to treat this disease,…”
Get full text
Journal Article Book Review -
14
An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus
Published in Neuro-oncology (Charlottesville, Va.) (02-11-2021)“…Abstract Background Oncolytic adenoviruses are promising new treatments against solid tumors, particularly for glioblastoma (GBM), and preclinical models are…”
Get full text
Journal Article -
15
Endovascular Selective Intra-Arterial Infusion of Mesenchymal Stem Cells Loaded With Delta-24 in a Canine Model
Published in Neurosurgery (01-01-2021)“…Abstract BACKGROUND Delta-24-RGD, an oncolytic adenovirus, shows promise against glioblastoma. To enhance virus delivery, we recently demonstrated that human…”
Get full text
Journal Article -
16
Retinal pigment epithelial cell death by the alternative complement cascade: role of membrane regulatory proteins, calcium, PKC, and oxidative stress
Published in Investigative ophthalmology & visual science (06-05-2014)“…Retinal pigment epithelial (RPE) cell death is an important feature of the advanced forms of AMD. Complement alternative pathway (AP) activation is associated…”
Get full text
Journal Article -
17
Loss of mTORC2 signaling in oligodendrocyte precursor cells delays myelination
Published in PloS one (21-11-2017)“…Myelin abnormalities are increasingly being recognized as an important component of a number of neurologic developmental disorders. The integration of many…”
Get full text
Journal Article -
18
Targeting the Tumor Microenvironment in Brain Metastasis
Published in Neurosurgery clinics of North America (01-10-2020)“…Dynamic interplay between cancer cells and the surrounding microenvironment is a feature of the metastatic process. Successful metastatic brain colonization…”
Get full text
Journal Article -
19
The genomic alterations in glioblastoma influence the levels of CSF metabolites
Published in Acta neuropathologica communications (19-01-2024)“…Cerebrospinal fluid (CSF) analysis is underutilized in patients with glioblastoma (GBM), partly due to a lack of studies demonstrating the clinical utility of…”
Get full text
Journal Article -
20
RNAi technology targeting the FGFR3-TACC3 fusion breakpoint: an opportunity for precision medicine
Published in Neuro-oncology advances (01-01-2020)“…Abstract Background Fusion genes form as a result of abnormal chromosomal rearrangements linking previously separate genes into one transcript. The FGFR3-TACC3…”
Get full text
Journal Article